Finance

Lists
3164:TPE
GenMont Biotech Inc
NT$16.65
-0.60%
(-0.10) 1D
Nov 6, 1:30:10 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 3164...
Open
NT$16.30
High
NT$17.00
Low
NT$15.55
Mkt. cap
1.43B
Avg. vol.
49.33K
Volume
80.04K
Dividend
4.80%
Quarterly dividend
NT$0.20
Ex-dividend date
Apr 8, 2026
P/E ratio
20.77
52-wk high
NT$19.75
52-wk low
NT$15.35
EPS
NT$0.80
Shares outstanding
88.91M
No. of employees
147
Open
NT$16.30
High
NT$17.00
Low
NT$15.55
Mkt. cap
1.43B
Avg. vol.
49.33K
Volume
80.04K
Dividend
4.80%
Quarterly dividend
NT$0.20
Ex-dividend date
Apr 8, 2026
P/E ratio
20.77
52-wk high
NT$19.75
52-wk low
NT$15.35
EPS
NT$0.80
Shares outstanding
88.91M
No. of employees
147
News stories
From web sources and news partners
About GenMont Biotech Inc
CEO-
Employees147
Founded2000
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegenmont.com.tw
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
88.90M
100.70M
89.17M
103.33M
Cost of goods sold
33.41M
38.03M
40.95M
42.22M
Cost of revenue
33.41M
38.03M
40.95M
42.22M
Research and development expenses
11.02M
11.62M
10.48M
11.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37.01M
38.04M
35.28M
36.36M
Operating expense
46.77M
50.91M
55.40M
46.42M
Total operating expenses
80.18M
88.94M
96.35M
88.64M
Operating income
8.72M
11.76M
-7.18M
14.70M
Other non operating income
586.00K
374.00K
61.00K
81.00K
EBT including unusual items
28.68M
29.47M
3.38M
19.56M
EBT excluding unusual items
23.39M
29.47M
3.38M
19.56M
Income tax expense
6.38M
7.16M
1.58M
6.70M
Effective tax rate
22.26%
24.31%
46.60%
34.27%
Other operating expenses
-
-
-
-
Net income
24.68M
24.80M
4.15M
15.54M
Net profit margin
27.76%
24.62%
4.65%
15.04%
Earnings per share
-
-
-
-
Interest and investment income
1.74M
1.55M
1.62M
1.69M
Interest expense
-953.00K
-900.00K
-937.00K
-1.03M
Net interest expenses
784.00K
651.00K
685.00K
654.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
24.07M
27.26M
9.11M
31.09M
Gain or loss from assets sale
-
1.00K
-
7.00K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps